Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Vaccines

Free Subscription Articles published in Infect Immun Retrieve available abstracts of 35 articles: HTML format

Single Articles

April 2024
1. XING Y, Clark JR, Chang JD, Zulk JJ, et al
   Progress toward a vaccine for extraintestinal pathogenic E. coli (ExPEC) II: efficacy of a toxin-autotransporter dual antigen approach.
   Infect Immun. 2024 Apr 9:e0044023. doi: 10.1128/iai.00440.
   PubMed     Abstract available
   
   
   March 2024
2. VANCE DJ, Basir S, Piazza CL, Willsey GG, et al
   Single-domain antibodies reveal unique borrelicidal epitopes on the Lyme disease vaccine antigen, outer surface protein A (OspA).
   Infect Immun. 2024 Mar 12:e0008424. doi: 10.1128/iai.00084.
   PubMed     Abstract available
   
   
   February 2024
3. KHAKHUM N, Baruch-Torres N, Stockton JL, Chapartegui-Gonzalez I, et al
   Decoration of Burkholderia Hcp1 protein to virus-like particles as a vaccine delivery platform.
   Infect Immun. 2024 Feb 14:e0001924. doi: 10.1128/iai.00019.
   PubMed     Abstract available
   
   
   
4. DEJONG MA, Wolf MA, Bitzer GJ, Hall JM, et al
   BECC438b TLR4 agonist supports unique immune response profiles from nasal and muscular DTaP pertussis vaccines in murine challenge models.
   Infect Immun. 2024 Feb 7:e0022323. doi: 10.1128/iai.00223.
   PubMed     Abstract available
   
   
   January 2024
5. BARNES KB, Brett P, Burtnick M, Vente A, et al
   Layering vaccination with antibiotic therapy results in protection and clearance of Burkholderia pseudomallei in Balb/c mice.
   Infect Immun. 2024 Jan 30:e0045523. doi: 10.1128/iai.00455.
   PubMed     Abstract available
   
   
   November 2023
6. GRAY MC, Thomas KS, Lamb ER, Werner LM, et al
   Evaluating vaccine-elicited antibody activities against Neisseria gonorrhoeae: cross-protective responses elicited by the 4CMenB meningococcal vaccine.
   Infect Immun. 2023 Nov 22:e0030923. doi: 10.1128/iai.00309.
   PubMed     Abstract available
   
   
   
7. MOUSTAFA DA, DiGiandomenico A, Raghuram V, Schulman M, et al
   Efficacy of a Pseudomonas aeruginosa serogroup O9 vaccine.
   Infect Immun. 2023 Nov 22:e0024723. doi: 10.1128/iai.00247.
   PubMed     Abstract available
   
   
   
8. LU C, Wang J, Zhong G
   Preclinical screen for protection efficacy of chlamydial antigens that are immunogenic in humans.
   Infect Immun. 2023;91:e0034923.
   PubMed     Abstract available
   
   
   
9. LIU Q, Li B, Lu J, Zhang Y, et al
   Recombinant outer membrane vesicles delivering eukaryotic expression plasmid of cytokines act as enhanced adjuvants against Helicobacter pylori infection in mice.
   Infect Immun. 2023;91:e0031323.
   PubMed     Abstract available
   
   
   
10. LI S, Anvari S, Ptacek G, Upadhyay I, et al
    A broadly immunogenic polyvalent Shigella multiepitope fusion antigen protein protects against Shigella sonnei and Shigella flexneri lethal pulmonary challenges in mice.
    Infect Immun. 2023;91:e0031623.
    PubMed     Abstract available
    
    
    
11. MARTINEZ FG, Zielke RA, Fougeroux CE, Li L, et al
    Development of a Tag/Catcher-mediated capsid virus-like particle vaccine presenting the conserved Neisseria gonorrhoeae SliC antigen that blocks human lysozyme.
    Infect Immun. 2023 Nov 2:e0024523. doi: 10.1128/iai.00245.
    PubMed     Abstract available
    
    
    October 2023
12. UPADHYAY I, Parvej SMD, Shen Y, Li S, et al
    Protein-based vaccine candidate MecVax broadly protects against enterotoxigenic Escherichia coli intestinal colonization in a rabbit model.
    Infect Immun. 2023 Oct 24:e0027223. doi: 10.1128/iai.00272.
    PubMed     Abstract available
    
    
    
13. HE Y, Wang Y, He R, Abdelsalam AM, et al
    IL-23 receptor signaling licenses group 3-like innate lymphoid cells to restrict a live-attenuated oral Chlamydia vaccine in the gut.
    Infect Immun. 2023 Oct 18:e0037123. doi: 10.1128/iai.00371.
    PubMed     Abstract available
    
    
    
14. BARTON A, Hill J, O'Connor D, Jones C, et al
    Early transcriptional responses to human enteric fever challenge.
    Infect Immun. 2023;91:e0010823.
    PubMed     Abstract available
    
    
    June 2023
15. KURTZ SL, Mittereder LR, Lehman CC, Khan H, et al
    Intravenous BCG Vaccination of Diversity Outbred Mice Results in Moderately Enhanced Protection against Challenge with Mycobacterium tuberculosis Compared to Intradermal Vaccination.
    Infect Immun. 2023 Jun 20:e0016823. doi: 10.1128/iai.00168.
    PubMed     Abstract available
    
    
    
16. PHAM T, Li Y, Watford W, Lin X, et al
    Vaccination with a ZNF2(oe) Strain of Cryptococcus Provides Long-Lasting Protection against Cryptococcosis and Is Effective in Immunocompromised Hosts.
    Infect Immun. 2023 Jun 20:e0019823. doi: 10.1128/iai.00198.
    PubMed     Abstract available
    
    
    
17. GUTIERREZ-SANCHEZ M, Carrasco-Yepez MM, Correa-Basurto J, Ramirez-Salinas GL, et al
    Two MP2CL5 Antigen Vaccines from Naegleria fowleri Stimulate the Immune Response against Meningitis in the BALB/c Model.
    Infect Immun. 2023 Jun 5:e0018123. doi: 10.1128/iai.00181.
    PubMed     Abstract available
    
    
    April 2023
18. WANG Y, He R, Winner H, Gauduin MC, et al
    Induction of Transmucosal Protection by Oral Vaccination with an Attenuated Chlamydia.
    Infect Immun. 2023 Apr 10:e0004323. doi: 10.1128/iai.00043.
    PubMed     Abstract available
    
    
    March 2023
19. WANG S, Ju X, Heuler J, Zhang K, et al
    Recombinant Fusion Protein Vaccine Containing Clostridioides difficile FliC and FliD Protects Mice against C. difficile Infection.
    Infect Immun. 2023 Mar 20:e0016922. doi: 10.1128/iai.00169.
    PubMed     Abstract available
    
    
    September 2022
20. FRYE AM, Ejemel M, Cavacini L, Wang Y, et al
    Agglutination of Borreliella burgdorferi by Transmission-Blocking OspA Monoclonal Antibodies and Monovalent Fab Fragments.
    Infect Immun. 2022;90:e0030622.
    PubMed     Abstract available
    
    
    
21. CAMIRE AC, O'Bier NS, Patel DT, Cramer NA, et al
    FtlA and FtlB Are Candidates for Inclusion in a Next-Generation Multiantigen Subunit Vaccine for Lyme Disease.
    Infect Immun. 2022 Sep 14:e0036422. doi: 10.1128/iai.00364.
    PubMed     Abstract available
    
    
    
22. SHAIKH MOF, Schaefers MM, Merakou C, DiBlasi M, et al
    Multicomponent Pseudomonas aeruginosa Vaccines Eliciting Th17 Cells and Functional Antibody Responses Confer Enhanced Protection against Experimental Acute Pneumonia in Mice.
    Infect Immun. 2022 Sep 7:e0020322. doi: 10.1128/iai.00203.
    PubMed     Abstract available
    
    
    July 2022
23. MAJUMDER S, Olson RM, Singh A, Wang X, et al
    Protection Induced by Oral Vaccination with a Recombinant Yersinia pseudotuberculosis Delivering Yersinia pestis LcrV and F1 Antigens in Mice and Rats against Pneumonic Plague.
    Infect Immun. 2022 Jul 28:e0016522. doi: 10.1128/iai.00165.
    PubMed     Abstract available
    
    
    
24. BASSET A, Wall E, Mitsi E, Deshusses C, et al
    Targeted Transcriptomic Screen of Pneumococcal Genes Expressed during Murine and Human Infection.
    Infect Immun. 2022;90:e0017522.
    PubMed     Abstract available
    
    
    
25. SCHMIDT LK, Orne CE, Shaffer TL, Wilson SM, et al
    Development of Melioidosis Subunit Vaccines Using an Enzymatically Inactive Burkholderia pseudomallei AhpC.
    Infect Immun. 2022 Jul 11:e0022222. doi: 10.1128/iai.00222.
    PubMed     Abstract available
    
    
    June 2022
26. DAYAO DA, Jaskiewcz J, Lee S, Oliveira BC, et al
    Development of Two Mouse Models for Vaccine Evaluation against Cryptosporidiosis.
    Infect Immun. 2022 Jun 23:e0012722. doi: 10.1128/iai.00127.
    PubMed     Abstract available
    
    
    May 2022
27. KAUR R, Pichichero M
    Lipidation of Haemophilus influenzae Antigens P6 and OMP26 Improves Immunogenicity and Protection against Nasopharyngeal Colonization and Ear Infection.
    Infect Immun. 2022;90:e0067821.
    PubMed     Abstract available
    
    
    January 2022
28. ZHOU Z, Tian Q, Wang L, Zhong G, et al
    Chlamydia deficient in plasmid-encoded glycoprotein 3 (pGP3) as an attenuated live oral vaccine.
    Infect Immun. 2022 Jan 31:IAI0047221. doi: 10.1128/IAI.00472.
    PubMed     Abstract available
    
    
    
29. CHAN WY, Entwisle C, Ercoli G, Ramos-Sevillano E, et al
    Correction for Chan et al., "A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge".
    Infect Immun. 2022;90:e0063921.
    PubMed    
    
    
    
30. CHAN WY, Entwisle C, Ercoli G, Ramos-Sevillano E, et al
    Corrected and Republished from: "A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge".
    Infect Immun. 2022;90:e0084618a.
    PubMed     Abstract available
    
    
    
31. SAKATANI H, Kono M, Nanushaj D, Murakami D, et al
    A novel pneumococcal surface protein K of nonencapsulated Streptococcus pneumoniae promotes transmission among littermates in an infant mouse model with influenza A virus co-infection.
    Infect Immun. 2022 Jan 3:iai0062221. doi: 10.1128/iai.00622.
    PubMed     Abstract available
    
    
    November 2021
32. HALL JM, Bitzer GJ, DeJong MA, Kang J, et al
    Mucosal Immunization with DTaP Confers Protection against Bordetella pertussis Infection and Cough in Sprague-Dawley Rats.
    Infect Immun. 2021;89:e0034621.
    PubMed     Abstract available
    
    
    October 2021
33. TEIXEIRA AF, Gillespie A, Yirsaw A, Britton E, et al
    Identification of leptospiral protein antigens recognized by WC1(+) gammadelta T cell subsets as target for development of recombinant vaccines.
    Infect Immun. 2021 Oct 25:IAI0049221. doi: 10.1128/IAI.00492.
    PubMed     Abstract available
    
    
    
34. GUO M, Guo X, Zhang C, Zhu S, et al
    A novel pneumococcal protein-polysaccharide conjugate vaccine based on biotin-streptavidin.
    Infect Immun. 2021 Oct 25:IAI0035221. doi: 10.1128/IAI.00352.
    PubMed     Abstract available
    
    
    
35. LI P, Wang X, Sun X, Cimino J, et al
    Recombinant Pseudomonas Bionanoparticles Induce Protection against Pneumonic Pseudomonas aeruginosa Infection.
    Infect Immun. 2021;89:e0039621.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.